KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Edwards Lifesciences (EW) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Edwards Lifesciences (EW) over the last 16 years, with Q3 2025 value amounting to 0.12%.

  • Edwards Lifesciences' Return on Invested Capital fell 300.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.14% for FY2024, which is 300.0% down from last year.
  • As of Q3 2025, Edwards Lifesciences' Return on Invested Capital stood at 0.12%, which was down 300.0% from 0.12% recorded in Q2 2025.
  • Edwards Lifesciences' Return on Invested Capital's 5-year high stood at 0.3% during Q2 2021, with a 5-year trough of 0.12% in Q3 2025.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.17% (2024), whereas its average is 0.19%.
  • Examining YoY changes over the last 5 years, Edwards Lifesciences' Return on Invested Capital showed a top increase of 1100bps in 2021 and a maximum decrease of -800bps in 2021.
  • Edwards Lifesciences' Return on Invested Capital (Quarter) stood at 0.25% in 2021, then decreased by -17bps to 0.21% in 2022, then fell by -17bps to 0.17% in 2023, then decreased by -29bps to 0.12% in 2024, then fell by -5bps to 0.12% in 2025.
  • Its last three reported values are 0.12% in Q3 2025, 0.12% for Q2 2025, and 0.12% during Q1 2025.